Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

HeartSciences Inc.

HSCS Nasdaq SEC CIK 1468492
Follow HeartSciences Weekly email: filings, results, news

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $2.1K +10.5% vs same quarter last year
Net income −$3.2M −54.4% vs same quarter last year
EPS, diluted −$0.86 +45.6% vs same quarter last year
Operating cash flow −$1.3M +32.5% vs same quarter last year
Revenue by quarter
$0
$4.4K
$1.9K
$2.4K
$0
$0
$2.1K
Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$10M−$7.5M−$5M−$2.5M$0$2.5MFY21FY22FY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$4.3K−$9.1M
FY25$4.4K−$8.8M
FY24$18.6K−$6.6M
FY23$5.2K−$6.4M
FY22$14.4K−$4.8M
FY21--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300000%−200000%−100000%0%100000%FY21FY22FY23FY24FY25FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2659.1%−194787.4%−211666.5%
FY2556.8%−192013.1%−201499.5%
FY2467.3%−33902%−35511.9%
FY2345.7%−118698.3%−123384.3%
FY2245.1%−32765.6%−33592.6%
FY21---
Free cash flowOperating cash flow minus capital expenditure
−$8M−$6M−$4M−$2M$0FY21FY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$7.4M
FY25−$7.4M
FY24−$6.1M
FY23−$5.8M
FY22−$3.6M
FY21-
Net margin vs the sectorMedian of Financials companies filing with the SEC
  • HeartSciences
  • Financials median
−300000%−200000%−100000%0%100000%FY21FY22FY23FY24FY25FY26
Show the numbers
YearHeartSciencesFinancials median
FY26−211666.5%-
FY25−201499.5%18.2%
FY24−35511.9%17.4%
FY23−123384.3%15.4%
FY22−33592.6%15.5%
FY21-21.7%

News

No stories filed under HeartSciences yet - coverage appears here as the news feed clusters it.